{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:11:03Z","timestamp":1773079863292,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.3816\/ccc.2007.n.008","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:06:13Z","timestamp":1221080773000},"page":"382-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Palmar-Plantar Erythrodysesthesia Associated with Scrotal and Penile Involvement with Capecitabine"],"prefix":"10.3816","volume":"6","author":[{"given":"Christy M.","family":"Sapp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"DeSimone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CCC.2007.n.008_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1081\/CNV-120000360","article-title":"Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience","volume":"20","author":"Abushullaih","year":"2002","journal-title":"Cancer Investigation"},{"key":"10.3816\/CCC.2007.n.008_bib2","first-page":"103","article-title":"Palmar-plantar erythrodysesthesia","volume":"1","author":"Wilkes","year":"2005","journal-title":"Clin J Oncol Nurs"},{"key":"10.3816\/CCC.2007.n.008_bib3","series-title":"Xeloda (capecitabine) tablets [package insert]","year":"2001"},{"key":"10.3816\/CCC.2007.n.008_bib4","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1200\/JCO.2001.19.21.4097","article-title":"Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study","volume":"19","author":"Van Custem","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2007.n.008_bib5","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1056\/NEJMoa043116","article-title":"Capecitabine as adjuvant treatment for stage III colon cancer","volume":"352","author":"Twelves","year":"2005","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2007.n.008_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00128071-200001040-00004","article-title":"Antineoplastic therapy-induced palmar plantar erythrodysesthesia (\u2018hand-foot\u2019) syndrome. Incidence, recognition and management","volume":"1","author":"Nagore","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.3816\/CCC.2007.n.008_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0959-8049(96)00497-2","article-title":"Hand-foot syndrome induced by high-dose, short term, continuous 5-fluorouracil infusion","volume":"33","author":"Chiara","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.3816\/CCC.2007.n.008_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00000421-200212000-00015","article-title":"Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer","volume":"25","author":"Eich","year":"2002","journal-title":"Am J Clin Oncol"},{"issue":"suppl 4","key":"10.3816\/CCC.2007.n.008_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2165\/00003495-199700544-00007","article-title":"Safety aspects of pegylated liposomal doxorubicin in patients with cancer","volume":"54","author":"Alberts","year":"1997","journal-title":"Drugs"},{"key":"10.3816\/CCC.2007.n.008_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00128071-200405030-00010","article-title":"Penile involvement with hand-foot syndrome","volume":"5","author":"Sorscher","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.3816\/CCC.2007.n.008_bib11","first-page":"138b","article-title":"Celecoxib attenuated capecitabine induced hand-and-foot syndrome (HFS) and diarrhea and improved time to tumor progression in metastatic colorectal cancer","volume":"21","author":"Lin","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CCC.2007.n.008_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0190-9622(91)70073-B","article-title":"Chemotherapy-induced acral erythema","volume":"24","author":"Baack","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CCC.2007.n.008_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0190-9622(99)70488-3","article-title":"Mucocutaneous reactions to chemotherapy","volume":"40","author":"Susser","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CCC.2007.n.008_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ygyno.2004.02.019","article-title":"The effect of regional cooling on toxicity associated with intravenous infusion of pegylated liposomal doxorubicin in recurrent ovarian carcinoma","volume":"93","author":"Molpus","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.3816\/CCC.2007.n.008_bib15","first-page":"219","article-title":"Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine","volume":"6","author":"Saif","year":"2006","journal-title":"Clin Colorectal Cancer"},{"key":"10.3816\/CCC.2007.n.008_bib16","first-page":"392a","article-title":"Effect of pyridoxine on the incidence of palmar plantar erythroderma in patients receiving capecitabine","volume":"20","author":"Lauman","year":"2001","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811702675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811702675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:58:57Z","timestamp":1761519537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002811702675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1533002811702675"],"URL":"https:\/\/doi.org\/10.3816\/ccc.2007.n.008","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palmar-Plantar Erythrodysesthesia Associated with Scrotal and Penile Involvement with Capecitabine","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CCC.2007.n.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}